Robeco Institutional Asset Management B.V. purchased a new position in UiPath, Inc. (NYSE:PATH – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 16,263 shares of the company’s stock, valued at approximately $208,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. AdvisorNet Financial Inc boosted its position in shares of UiPath by 320.4% in the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock worth $32,000 after purchasing an additional 1,887 shares during the last quarter. CX Institutional bought a new position in UiPath during the first quarter worth about $36,000. GAMMA Investing LLC lifted its holdings in UiPath by 48.0% during the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after acquiring an additional 969 shares in the last quarter. Brooklyn Investment Group lifted its holdings in UiPath by 314.3% during the first quarter. Brooklyn Investment Group now owns 4,508 shares of the company’s stock worth $46,000 after acquiring an additional 3,420 shares in the last quarter. Finally, National Bank of Canada FI bought a new position in UiPath during the first quarter worth about $72,000. 62.50% of the stock is currently owned by institutional investors.
Insider Transactions at UiPath
In related news, insider Brad Brubaker sold 66,665 shares of UiPath stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $15.00, for a total transaction of $999,975.00. Following the completion of the transaction, the insider owned 690,519 shares in the company, valued at approximately $10,357,785. This trade represents a 8.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Daniel Dines sold 122,734 shares of UiPath stock in a transaction dated Wednesday, October 8th. The stock was sold at an average price of $14.89, for a total value of $1,827,509.26. Following the transaction, the chief executive officer owned 736,404 shares of the company’s stock, valued at $10,965,055.56. The trade was a 14.29% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,692,334 shares of company stock valued at $21,619,319 in the last quarter. 23.19% of the stock is currently owned by corporate insiders.
UiPath Stock Performance
UiPath (NYSE:PATH – Get Free Report) last released its earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.07. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The business had revenue of $361.73 million for the quarter, compared to the consensus estimate of $347.36 million. During the same quarter in the previous year, the business earned $0.04 earnings per share. UiPath’s quarterly revenue was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, equities analysts predict that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
PATH has been the topic of several recent analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of UiPath in a report on Wednesday. Canaccord Genuity Group reduced their target price on UiPath from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Monday, September 8th. Cowen reiterated a “hold” rating on shares of UiPath in a report on Friday, September 5th. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research note on Friday, September 5th. Finally, Zacks Research raised UiPath from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 8th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UiPath currently has an average rating of “Hold” and a consensus price target of $13.21.
Read Our Latest Research Report on PATH
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More
- Five stocks we like better than UiPath
- What is the Nasdaq? Complete Overview with History
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Quiet Period Expirations Explained
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- What Are Dividends? Buy the Best Dividend Stocks
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.